Six papers
by Qiang Zhang
- D Hoer, HA Barton, A Paini, M Bartels, B Ingle, J Domoradzki, J Fisher, M Embry, P Villanueva, D Miller, J Nguyen, Q Zhang, SW Edwards, and YM Tan. Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling. Toxicol Appl Pharmacol 440 : 115922 (Feb 15, 2022). [abstract] [pubmed]
- P Xue, Y Hou, Z Zuo, Z Wang, S Ren, J Dong, J Fu, H Wang, ME Andersen, Q Zhang, Y Xu, and J Pi. Long isoforms of NRF1 negatively regulate adipogenesis via suppression of PPARĪ³ expression. Redox Biol 30 : 101414 (Feb 28, 2020). [abstract] [pubmed]
- L Li, J Fu, D Liu, J Sun, Y Hou, C Chen, J Shao, L Wang, X Wang, R Zhao, H Wang, ME Andersen, Q Zhang, Y Xu, and J Pi. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARĪ³ expression. Redox Biol 30 : 101412 (Feb 23, 2020). [abstract] [pubmed]
- Q Zhang, WM Caudle, J Pi, S Bhattacharya, ME Andersen, NE Kaminski, and RB Conolly. Embracing Systems Toxicology at Single-Cell Resolution. Curr Opin Toxicol 16 : 49-57 (Aug 19, 2019). [abstract] [pubmed]
- Y Hou, Z Liu, Z Zuo, T Gao, J Fu, H Wang, Y Xu, D Liu, M Yamamoto, B Zhu, Y Zhang, ME Andersen, Q Zhang, and J Pi. Adipocyte-specific deficiency of Nfe2l1 disrupts plasticity of white adipose tissues and metabolic homeostasis in mice. Biochem Biophys Res Commun 503 (1) : 264-270 (Sep 3, 2018). [abstract] [pubmed]
- J Zhu, H Wang, F Chen, J Fu, Y Xu, Y Hou, HH Kou, C Zhai, MB Nelson, Q Zhang, ME Andersen, and J Pi. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy. Free Radic Biol Med 99 : 544-556 (Oct 12, 2016). [abstract] [pubmed]